TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Thomas Jefferson University
Center for International Blood and Marrow Transplant Research
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Case Comprehensive Cancer Center
City of Hope Medical Center
Thomas Jefferson University
Heinrich-Heine University, Duesseldorf
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
University of California, San Francisco
OHSU Knight Cancer Institute
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Yale University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
National Cancer Institute (NCI)
Northside Hospital, Inc.
Northside Hospital, Inc.
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
University of California, San Francisco
Northside Hospital, Inc.
Northside Hospital, Inc.
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins